Literature DB >> 25748143

Patterns of lymph node metastasis from nasopharyngeal carcinoma based on the 2013 updated consensus guidelines for neck node levels.

XiaoShen Wang1, ChaoSu Hu2, HongMei Ying1, XiaYun He1, GuoPei Zhu1, Lin Kong1, JianHui Ding3.   

Abstract

PURPOSE: To explore patterns of node distribution in nasopharyngeal carcinoma (NPC) based on the 2013 updated guidelines for neck node levels. METHODS AND MATERIALS: We retrospectively reviewed the imaging documents of 3100 cases of newly diagnosed NPC between January 2010 and January 2013. All patients received an MRI scan. The scan range extended from 2 cm above the anterior clinoid process to the inferior margin of the sternal end of the clavicle. All MR images were evaluated by the multi-disciplinary treatment group of NPC.
RESULTS: A total of 2679 (86.4%) cases had involved lymph nodes. The detailed distribution was: level Ia 0, level Ib 115 (4.3%), level IIa 1798 (67.1%), level IIb 2341 (87.4%), level III 1184 (44.2%), level IVa 350 (13.1%), level IVb 28 (1.0%), level Va,b 995 (37.1%), level Vc 49 (1.8%), level VI 0, level VIIa 2012 (75.1%), level VIIb 178 (6.6%), level VIII 53 (2.0%), level IX 2, level Xa 2, level Xb 3. Among patients with level VII involvement, only 6 (0.3%) were located at the medial group. Of the patients with level II disease, the upper borders of metastatic nodes in 25.9% cases were beyond the caudal edge of C1. Patients with level VIII, or IX, or X node metastasis were always with extensive ipsilateral lymphadenopathy, and the total number of involved nodes was ⩾6. There were 35 cases of lymphadenopathy beyond the range of the updated guidelines, located inside the trapezius muscles, but posterior to level V.
CONCLUSIONS: This is the first description of nodal spread patterns based on the updated consensus guidelines. Involvement of the retropharyngeal nodes was mainly located at the lateral group, the medial group was rarely seen. The suggested upper border of level II cannot fully cover all the involved level II nodes. The posterior level V border is not enough to cover all level V lymphadenopathies for NPC.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Clinical target volume; Consensus guidelines; Magnetic resonance imaging; Nasopharyngeal carcinoma

Mesh:

Year:  2015        PMID: 25748143     DOI: 10.1016/j.radonc.2015.02.017

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  26 in total

1.  Omitting the lower neck and sparing the glottic larynx in node-negative nasopharyngeal carcinoma was safe and feasible, and improved patient-reported voice outcomes.

Authors:  F Xiao; S Dou; Y Li; W Qian; F Liang; L Kong; X Wang; K Wu; C Hu; G Zhu
Journal:  Clin Transl Oncol       Date:  2018-12-04       Impact factor: 3.405

Review 2.  Intensity-modulated radiotherapy for head and neck surgeons.

Authors:  Stanley I Gutiontov; Edward J Shin; Benjamin Lok; Nancy Y Lee; Ruben Cabanillas
Journal:  Head Neck       Date:  2015-12-26       Impact factor: 3.147

3.  Analysis of geometric variation of neck node levels during image-guided radiotherapy for nasopharyngeal carcinoma: recommended planning margins.

Authors:  Wenyong Tan; Yingjie Wang; Ming Yang; Richard A Amos; Weihao Li; Jianzeng Ye; Royle Gary; Weixi Shen; Desheng Hu
Journal:  Quant Imaging Med Surg       Date:  2018-08

4.  MRI-based radiomics as response predictor to radiochemotherapy for metastatic cervical lymph node in nasopharyngeal carcinoma.

Authors:  Hao Xu; Jieke Liu; Ying Huang; Peng Zhou; Jing Ren
Journal:  Br J Radiol       Date:  2021-04-21       Impact factor: 3.629

5.  High-risk factors of parotid lymph node metastasis in nasopharyngeal carcinoma: a case-control study.

Authors:  Hong-Zhi Wang; Cai-Neng Cao; Jing-Wei Luo; Jun-Lin Yi; Xiao-Dong Huang; Shi-Ping Zhang; Kai Wang; Yuan Qu; Jian-Ping Xiao; Su-Yan Li; Li Gao; Guo-Zhen Xu
Journal:  Radiat Oncol       Date:  2016-09-01       Impact factor: 3.481

6.  Advantage of PET/CT in Target Delineation of MRI-negative Cervical Lymph Nodes In Intensity-Modulated Radiation Therapy Planning for Nasopharyngeal Carcinoma.

Authors:  Guanzhu Shen; Weiwei Xiao; Fei Han; Wei Fan; Xiao-Ping Lin; Lixia Lu; Lie Zheng; Ning Yue; Bruce Haffty; Chong Zhao; Xiaowu Deng
Journal:  J Cancer       Date:  2017-11-06       Impact factor: 4.207

7.  Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.

Authors:  Hao Peng; Lei Chen; Ling-Long Tang; Wen-Fei Li; Yan-Ping Mao; Rui Guo; Yuan Zhang; Li-Zhi Liu; Li Tian; Xu Zhang; Xiao-Ping Lin; Ying Guo; Ying Sun; Jun Ma
Journal:  Chin J Cancer       Date:  2017-12-19

8.  Role of diffusion-weighted imaging in the discrimination of benign and metastatic parotid area lymph nodes in patients with nasopharyngeal carcinoma.

Authors:  Chuanben Chen; Zhizhong Lin; Youping Xiao; Penggang Bai; Qiuyuan Yue; Yunbin Chen; Lisha Chen
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

9.  The diagnostic value of 1.5-T diffusion-weighted MR imaging in detecting 5 to 10 mm metastatic cervical lymph nodes of nasopharyngeal carcinoma.

Authors:  Guan Qiao Jin; Jun Yang; Li Dong Liu; Dan Ke Su; Duo Ping Wang; Sheng Fa Zhao; Zhi Ling Liao
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

10.  Parotid area lymph node metastases from preliminarily diagnosed patients with nasopharyngeal carcinoma: report on tumor characteristics and oncologic outcomes.

Authors:  Yuanji Xu; Mingwei Zhang; Youping Xiao; Jingfeng Zong; Sufang Qiu; Penggang Bai; Yitao Dai; Lin Zhou; Xiaolin Chen; Wei Zheng; Yunbin Chen; Shaojun Lin; Jianji Pan
Journal:  Oncotarget       Date:  2016-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.